Similar Stories to Here's Why Marinus Pharmaceuticals Is Soaring Today on Bing News

Welcome to the popular clique, kid. Shares of clinical-stage biopharma Marinus Pharmaceuticals (NASDAQ: MRNS) rose as much as 22.2% by noon EST after the company announced it will be added to the coveted NASDAQ Biotechnology Index on Dec. 18. The index includes biopharma and (oddly) pharmaceutical companies that meet certain eligibility requirements such as a minimum market cap. The NASDAQ Biotechnology Index is adjusted annually, and this year Marinus Pharmaceuticals made the cut.

BING NEWS:
  • ‘Junk patents’ by big pharma lead to soaring drugs prices, FTC says
    The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to the United States Department of Health and Human Services. Some federal ...
    05/31/2024 - 1:28 am | View Link
  • India's pharma export sales to grow faster this year, trade body says
    India's pharmaceutical export sales growth is expected to pick up to nearly 11% this fiscal year, from a roughly 10% increase last year, led by the key U.S. and UK markets, a government-backed trade ...
    05/29/2024 - 9:53 pm | View Link
  • Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
    Data from an earlier cut-off date shows that treatment with Merus' (MRUS) combination therapy achieved a 60% response rate in patients with head and neck cancer.
    05/27/2024 - 12:36 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News